Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8409568 Mutant antibody Fc domains and fusion proteins thereof

Patent 8409568 was granted and assigned to MedImmune on April, 2013 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Current Assignee
MedImmune
MedImmune
Date Filed
July 15, 2010
Date of Patent
April 2, 2013
Patent Application Number
12837208
Patent Citations Received
‌
US Patent 12129309 Heterodimeric antibodies that bind CD3 and CD38
0
‌
US Patent 11859012 Heterodimeric antibodies that bind CD3 and GPC3
0
‌
US Patent 11919956 Heterodimeric antibodies that bind prostate specific membrane antigen (PSMA) and CD3
0
‌
US Patent 11919958 Anti-CD28 compositions
0
‌
US Patent 11945880 Heterodimeric antibodies that bind CD3 and tumor antigens
0
‌
US Patent 11840579 Bispecific antibodies that bind to CD38 and CD3
0
Patent Inventor Names
Changshou Gao
0
Herren Wu
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8409568
Patent Primary Examiner
‌
Christopher M Gross

Find more entities like US Patent 8409568 Mutant antibody Fc domains and fusion proteins thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.